RNU7-115P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU7-115P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU7-115P data layer compared with 1 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU7-115P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-115P expression acts as an unfavorable survival marker, although some lineages such as BLCA and CHOL show a favorable association.

KIRC, BLCA, and CESC are the cancer types where RNU7-115P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCDFSTertileAll0.4400.657<.001156view →
BLCAOSTertileAll0.8220.682.001105view →
CESCOSTertileII,III,IV0.4880.814<.00160view →
COADOSTertileII,III,IV0.3750.612.00134view →
UVMOSTertileAll0.2920.674.03518view →
SKCMDFSTertileIV0.0670.524.00618view →
ACCDFSTertileII,III,IV0.1450.547.02112view →
CHOLDFSMedianIV0.8580.339.0179view →
KICHDFSTertileIII,IV0.0430.897.0459view →
STADDFSQuartileIII,IV0.7250.289.0237view →
READOSTertileAll0.9570.571.0486view →
LUSCDFSTertileII,III,IV0.5610.341.0306view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU7-115P–KIRC (DFS)

Kaplan–Meier survival curve for RNU7-115P RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration